Myriad Genetics, Inc. (LON:0K3W)
London · Delayed Price · Currency is GBP · Price in USD 6.35
-0.32 (-4.78%)
At close: Nov 6, 2025
Myriad Genetics Market Cap
Myriad Genetics has a market cap or net worth of 450.23 million as of November 7, 2025. Its market cap has decreased by -71.55% in one year.
Market Cap
450.23M
Enterprise Value
501.28M
Revenue
613.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.35
Market Cap Chart
Since October 6, 1995, Myriad Genetics's market cap has increased from 110.60M to 450.23M, an increase of 307.08%. That is a compound annual growth rate of 4.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 450.23M | -54.84% |
| Dec 31, 2024 | 996.94M | -25.18% |
| Dec 29, 2023 | 1.33B | 36.53% |
| Dec 30, 2022 | 975.86M | -40.05% |
| Dec 31, 2021 | 1.63B | 49.42% |
| Dec 31, 2020 | 1.09B | -28.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.06B |
| GSK plc | 71.94B |
| Haleon | 31.81B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 3.90B |
| HUTCHMED (China) | 1.96B |
| Genus | 1.65B |